Breaking: Chimamanda Adichie’s Son Dies, Hospital Opens Probe Into Circumstances

Euracare Multispecialist Hospital Speaks Out Following Chimamanda Adichie’s Son’s Death, Launches Investigation

Euracare Multispecialist Hospital has issued a statement regarding the tragic death of 21-month-old Nkanu Nnamdi, son of acclaimed Nigerian author Chimamanda Ngozi Adichie, announcing that an internal investigation into the incident has been initiated.

The hospital’s response comes after Adichie publicly alleged that medical negligence at the Lagos-based facility contributed to her son’s death on Wednesday, January 7, 2026. According to the author, inadequate monitoring after Nkanu was sedated with propofol for an MRI scan and the insertion of a central line led to severe complications, including loss of responsiveness, seizures, and cardiac arrest.

In its statement, Euracare expressed profound sympathy to the family, describing the loss as “devastating” and offering condolences:

“We extend our deepest sympathies to Chimamanda Adichie and family on the demise of their son and acknowledge the profound and unimaginable loss they are experiencing during this deeply distressing time. The loss of a child is beyond words, and we offer our most heartfelt condolences to his parents and the entire family.”

The hospital emphasized that the statement was necessary due to widespread public discussion and misinformation, noting that not all reports circulating were accurate.

Euracare clarified that Nkanu was already in critical condition before being brought to their facility and had received prior treatment at two pediatric centers.

“The patient, who was critically ill, was referred to our facility for specific diagnostic procedures after receiving treatment for a period of time at two pediatric centres,” the statement read.

The hospital assured that its medical team provided care in accordance with established clinical protocols and internationally accepted standards, including sedation where clinically necessary. Euracare confirmed that a detailed internal review has begun, underscoring its commitment to transparency and adherence to due process:

“We have commenced a detailed investigation consistent with our clinical governance standards and best practices. We remain committed to engaging transparently and responsibly with all clinical and regulatory processes.”

Euracare also noted that it collaborated with external medical teams recommended by the family, providing all necessary clinical support, but regrettably, the child passed away less than 24 hours after arrival.

The hospital acknowledged the emotional toll on its staff and reaffirmed its dedication to compassion, patient safety, and respect for the family’s privacy:

“As medical professionals, we carry the weight of this loss deeply. Our priority remains compassion, patient safety, and the responsible handling of this matter, while respecting the family’s privacy and allowing due process to take its course.”

Euracare concluded by saying it will continue to keep the family in its thoughts and prayers as the investigation proceeds.